Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01N-037/12
A01N-037/44
A01N-037/00
A61K-031/195
A61K-031/185
A61K-031/21
출원번호
US-0724892
(2010-03-16)
등록번호
US-8575217
(2013-11-05)
발명자
/ 주소
Mian, Alec
Clauzel, Luc Marti
Mayoux, Eric
Garcia-Vicente, Silvia
Munoz, Marta Serrano
Olarte, Antonio Zorzano
Palomino Laria, Julio Cesar Castro
출원인 / 주소
Genmedica Therapeutics SL
대리인 / 주소
McDonnell Boehnen Hulbert & Berghoff LLP
인용정보
피인용 횟수 :
2인용 특허 :
42
초록▼
The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidan
The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants.
대표청구항▼
1. A method for treating a metabolic disorder selected from type I diabetes, type II diabetes, Latent Autoimmune Diabetes of Adulthood (LADA), hyperglycemia, elevated free fatty acids, elevated triglycerides and insulin resistance in a mammal or patient comprising administering to the mammal or pati
1. A method for treating a metabolic disorder selected from type I diabetes, type II diabetes, Latent Autoimmune Diabetes of Adulthood (LADA), hyperglycemia, elevated free fatty acids, elevated triglycerides and insulin resistance in a mammal or patient comprising administering to the mammal or patient in need of such treatment a therapeutically effective amount of (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid or a pharmaceutically acceptable salt thereof. 2. A method of treating Latent Autoimmune Diabetes of Adulthood (LADA), in a mammal or patient comprising administering to the mammal or patient in need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable carrier. 3. The method according to claim 1, wherein the metabolic disorder is Latent Autoimmune Diabetes of Adulthood (LADA). 4. The method according to claim 1, wherein the method provides beta cell protection. 5. The method according to claim 1, wherein the metabolic disorder is type II diabetes. 6. The method according to claim 1 wherein the metabolic disorder is hyperglycemia. 7. The method according to claim 1, wherein the metabolic disorder is elevated free fatty acids. 8. The method according to claim 1, wherein the metabolic disorder is elevated triglycerides. 9. The method according to claim 1, wherein the metabolic disorder is insulin resistance. 10. The method according to claim 1, wherein the (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid is administered as a pharmaceutically acceptable salt. 11. The method according to claim 1, wherein the (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid is administered as a L-lysine salt. 12. The method according to claim 1, wherein the (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid is administered as a pharmaceutical composition comprising (R)-2-acetamido-3-(2′,4′-difluoro-4-hydroxybiphenylcarbonylthio)propanoic acid or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable carrier.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (42)
Gobetti Marino (Milan ITX) Vandoni Guido (Correzzana ITX), Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them.
Chungi, Shubha; Iorio, Theodore L., Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin.
Zabrecky,George, Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis.
Malfroy Camine,Bernard; Doctrow,Susan Robin, Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases.
Shiff Steven ; Fisher Edward A. ; Weinstein I. Bernard ; Dansky Hayes M. ; Reiss Urnani, Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs.
Pacioretty, Linda M.; Babish, John G., Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology.
Chang, Han-Ting; Charmot, Dominique; Glinka, Tomasz; Cope, Michael James; Goka, Elizabeth; Shao, Jun; Cartigny, Damien; Chen, Shiah-yun; Buysse, Jerry M., Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors.
Herzenberg, Leonard A.; Herzenberg, Leonore A.; De Rosa, Stephen C.; Andrus, James, N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity.
Barker, Anna D.; Day, Robert W.; Dennis, Anthony J.; Farnsworth, Norman R.; Haack, Julie A.; McCord, Joseph M.; Potter, John D., Nutrient formulations for disease reduction.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.